FIFTH THIRD BANCORP

Bank

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 35527 CINCINNATI, OH

Position in LCTX

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$7,268,000

+$7,266,396 QoQ

Shares Held

4,600,000

+323843.7% QoQ

Ownership

1.85%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 131 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FIFTH THIRD BANCORP holds $165,893,632 across 150 Biotechnology names. LCTX ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	88,499	$39,518,343
2	REGN	Regeneron Pharmaceuticals, Inc.	34,910	$26,972,862
3	VCEL	Vericel Corp	256,688	$8,257,652
4	LCTX	Lineage Cell Therapeutics, Inc. This page	4,600,000	$7,268,000
5	TECH	BIO-TECHNE Corp	136,521	$7,134,587
6	APGE	Apogee Therapeutics, Inc.	63,800	$5,370,046
7	HALO	Halozyme Therapeutics, Inc.	68,128	$4,403,112
8	KYMR	Kymera Therapeutics, Inc.	51,238	$4,267,613

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,268,000	4,600,000	+323843.7%	Shares	Defined	2026-05-01
2022-09-30	$1,604	1,420	0.0%	Shares	Defined	2022-10-25
2022-06-30	$2,243	1,420	0.0%	Shares	Defined	2022-08-04
2022-03-31	$2,186	1,420	0.0%	Shares	Defined	2022-04-19
2021-12-31	$3,479	1,420	0.0%	Shares	Defined	2022-02-01
2021-09-30	$3,578	1,420	0.0%	Shares	Defined	2021-10-15
2021-06-30	$4,047	1,420	0.0%	Shares	Defined	2021-08-06
2021-03-31	$3,337	1,420	0.0%	Shares	Defined	2021-05-07
2020-12-31	$2,499	1,420	0.0%	Shares	Defined	2021-02-16
2020-09-30	$1,334	1,420	0.0%	Shares	Defined	2020-11-09
2020-06-30	$1,235	1,420	0.0%	Shares	Defined	2020-08-05
2020-03-31	$1,178	1,420	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.